Since 2005, CoMotion (formerly C4C) has supported the commercialization of more than 100 innovative ideas. Let our dedicated team connect you with UW researchers doing cutting-edge work.
When Ron Myers left the Institute for Systems Biology to become CEO of UW startup Nexgenia, he shifted the company’s direction to focus on one of the key challenges in commercializing immunotherapy: accurately and quickly sorting out the T cells from a patient’s blood so they can be activated and sent back into the patient’s body to battle cancer cells.
Come to An Event
Help Us Find Talent
To learn more about investor opportunities at UW, please contact:
Associate Director for Early Stage Funding